RI

Ruchika Irene Dillu

Active Director Director DIN 11228125
DIN 11228125 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ruchika Irene Dillu

Data last updated:

Ruchika Irene Dillu is a Director at Surabhi Pharmaceuticals Private Limited (since 2026) and Director at Irenemeds Private Limited (since 2025).

DIN 11228125
Primary Designation Director
First Appointment 04 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Aug 20262026Active
Irenemeds Private Limited U70200MH2025PTC453699
Director04 Aug 20252025Active

Board colleagues of Ruchika Irene Dillu

NameDINCompanyDesignation
Surabhi Mahendar Rao00178662Surabhi Pharmaceuticals Private LimitedManaging Director
Vikram Rana10250766Irenemeds Private LimitedDirector

Directorship timeline

Open interactive timeline →
Irenemeds Private Limited
Surabhi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ruchika Irene Dillu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruchika Irene Dillu

Ruchika Irene Dillu currently holds 2 directorships: Surabhi Pharmaceuticals Private Limited (Director, since 13 Aug 2026); Irenemeds Private Limited (Director, since 04 Aug 2025).

Ruchika Irene Dillu was first appointed on 04 Aug 2025 as Director at Irenemeds Private Limited. The most recent appointment on record is 13 Aug 2026 at Surabhi Pharmaceuticals Private Limited.

The current boards of Ruchika Irene Dillu's companies include Surabhi Mahendar Rao (Surabhi Pharmaceuticals Private Limited), Vikram Rana (Irenemeds Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available